Fri, May 7, 2021
Thu, May 6, 2021
Wed, May 5, 2021
Tue, May 4, 2021
Mon, May 3, 2021
Fri, April 30, 2021

Geoffrey Porges Maintained (TBPH) at Buy with Decreased Target to $39 on, May 5th, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-39-on-may-5th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Geoffrey Porges of SVB Leerink, Maintained "Theravance Biopharma, Inc." (TBPH) at Buy with Decreased Target from $40 to $39 on, May 5th, 2021.

Geoffrey has made no other calls on TBPH in the last 4 months.



There is 1 other peer that has a rating on TBPH. Out of the 1 peers that are also analyzing TBPH, 0 agree with Geoffrey's Rating of Hold.



This is the rating of the analyst that currently disagrees with Geoffrey


  • Vikram Purohit of "Morgan Stanley" Maintained at Buy with Decreased Target to $30 on, Monday, March 1st, 2021